Investing.com - Orthofix reported on Tuesday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Orthofix announced earnings per share of $0.09 on revenue of $114.00. Analysts polled by Investing.com anticipated EPS of $0.06 on revenue of $120.68M.
Orthofix shares are down 9% from the beginning of the year and are trading at $14.87 , down-from-52-week-high.
Orthofix follows other major Healthcare sector earnings this month
Orthofix's report follows an earnings beat by Exelixis on Tuesday, August 9, 2022, who reported EPS of $0.22 on revenue of $419.43M, compared to forecasts EPS of $0.203 on revenue of $391.03M.
Neogen had missed expectations on Tuesday, September 27, 2022 with first quarter EPS of $0.05 on revenue of $132.35M, compared to forecast for EPS of $0.105 on revenue of $135.75M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar